palmoplantar psoriasisustekinumabguselkumab
…(GA) after 3 years of successful ustekinumab therapy for severe palmoplantar psoriasis. Ustekinumab, an interleukin (IL)-12/23 inhibitor, was ceased a…
1articles mentioning diseases
1disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: palmoplantar psoriasis ×
palmoplantar psoriasis
This disease is selected. Its supporting articles are shown below.